Social News
Written by: Li Enci
2021-04-06 21:29
Last update date: 2021-04-06 21:29
The European Medicines Agency’s Vaccine Director Cavareri said today (6th) that the Oxford University/AstraZeneca AstraZeneca vaccine is related to the occurrence of blood clots in the vaccinated. The European Medicines Agency will confirm the connection in the next few hours and announce the vaccination. Complications that may occur later.
The Hong Kong government announced the purchase of three new crown pneumonia vaccines last year, one of which is the AstraZeneca vaccine.
Xu Shuchang, a member of the New Coronary Pneumonia Vaccine Advisory Committee and Chair Professor of Respiratory Department of CUHK, said that the two vaccines that have been purchased in Hong Kong are sufficient for all Hong Kong citizens to vaccinate, and the government is not recommended to purchase AstraZeneca vaccine.
As for whether the government should repurchase another adenovirus vector vaccine, Xu Shuchang said bluntly, "There is no need at all. It is better to keep the money back to buy a second-generation vaccine. It can target (prevent) the variant virus."
European Medicines Agency: AstraZeneca is obviously related to thrombosis
In an interview with the Italian media, the European Medicines Agency's vaccine director Cavalelli said that the blood clot is obviously related to the AstraZeneca vaccine, but it is not clear what caused it.
He added that among the vaccinators with blood clots in the brain, the number of young people was higher than they expected.
The European Medicines Agency hopes to clarify the situation as soon as possible and announce possible complications after vaccination.
Xu Shuchang, member of the New Coronary Pneumonia Vaccine Advisory Committee and Chair Professor of Respiratory Department of CUHK.
(Profile picture)
Xu Shuchang: AstraZeneca did not apply for emergency use in Hong Kong
Xu Shuchang said that the government does not recommend the purchase of AstraZeneca vaccine.
Since Hong Kong has purchased Coxing and Fubital vaccines, each has 7.5 million doses, or a total of 15 million doses, which is enough for all citizens of Hong Kong to receive two doses each; and the current measures to prevent importation in Hong Kong are well done, and there are not many cases. I believe that the two vaccines can meet the vaccination needs.
He continued that after reading reports and data from various countries, he was worried about the risk of thrombosis caused by the vaccine, and AstraZeneca has not yet applied for approval for emergency use in Hong Kong, and the expert committee does not need to study more clinical data for the time being.
When asked whether the government needs to sub-purchase another adenovirus vector vaccine, Xu Shuchang said bluntly, "I don't need it at all. It's better to save the money to buy a second-generation vaccine. It can target (prevent) the variant virus."
New crown pneumonia丨European Medicines Agency official: AstraZeneca vaccine is linked to blood clots
Thrombosis after vaccination with AstraZeneca's new crown vaccine, 7 deaths out of 30 cases in the UK
New crown pneumonia | The Netherlands suspends AstraZeneca vaccination for people under 60
New crown pneumonia｜Germany recommends the second dose of AstraZeneca vaccine to inject other products
AstraZeneca Vaccine丨European Medicines Agency: There is currently no evidence that the vaccine is related to thromboembolism
01News
New crown pneumonia new crown vaccine AstraZeneca vaccine new crown vaccine side effects